Sun Pharmaceutical Industries Ltd. closed 13.94% below its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

Welcome to the Sun Pharma Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most ...

Nagaraj Shetti of HDFC Securities recommends these two stocks to buy in the short-term - Bajaj Finserv Ltd, and Sun ...

Several Indian pharmaceutical companies are ushering in the next generation of their promoter families to take over the reins ...

Following these outcomes, Sun Pharma has decided to discontinue further clinical trials of SCD-044 and has no plans for its ...

Sun Pharmaceutical Industries is discontinuing two trials of its drug candidate SCD-044 for moderate to severe as psoriasis ...

Sun Pharmaceutical Industries Ltd. closed 14.30% below its 52-week high of 1,960.20 rupees, which the company reached on ...

Sun Pharma to invest $100 million in speciality products, targeting growth in innovative treatments for the future.

Sun Pharma's shares experienced a 0.47 per cent decline, trading at Rs 1,659.80, alongside the sharper fall in SPARC shares ...

Sun Pharmaceutical Industries, operating in the Pharmaceuticals sector and classified as a Largecap on the BSE, currently has its share price at ₹1689.45. The stock has experienced fluctuations ...

Stay informed with the Sun Pharma Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...